EffRx Pharmaceuticals is a commercial-stage pharmaceutical company focused on the late-stage development and commercialization of prescription medications for rare endocrine and metabolic disorders as well as musculoskeletal diseases.
EffRx Pharmaceuticals is a lean and agile, integrated, market-oriented biopharmaceutical company focused on niche therapeutics in Europe and in Switzerland. Our business strategy focuses on successfully shaping the late-stage development and launch to market of therapeutics for patients suffering from niche and rare diseases.
